College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai Health, Dubai, United Arab Emirates.
Department of Physiology, School of Health Sciences, University of Iceland, Reykjavík, Iceland.
Front Public Health. 2024 Aug 6;12:1384964. doi: 10.3389/fpubh.2024.1384964. eCollection 2024.
Hypertensive disorders of pregnancy are the second most common cause of maternal deaths worldwide. Metabolic syndrome is recognized as one of the risk factors for pre-eclampsia. A recent study revealed a high prevalence of metabolic syndrome in the United Arab Emirates (UAE), particularly amongst Emirati women compared with global estimates. This finding raises the possibility that the prevalence of pre-eclampsia in the region may also be higher as research is increasingly demonstrating an association between pre-eclampsia and metabolic syndrome. We therefore conducted this scoping review of the literature to investigate the nature and extent of studies evaluating the prevalence of pre-eclampsia within the Middle East region to enable subsequent comparison of these findings with the global burden of pre-eclampsia, objectively identify gaps in the literature and inform the design of future studies to address these gaps. PubMed and Scopus were used to extract studies published over the last 20 years (2003-2023). The search terms used included ("Pre-eclampsia" AND "Prevalence") OR ("Hypertension in pregnancy" AND "Prevalence") OR ("Pregnancy" AND "Pre-eclampsia") OR ("Pre-eclampsia" AND "Epidemiology"). We limited our studies to those from the Middle East (ME). A total of 556 relevant articles were identified following which 11 were shortlisted for review. There were four studies from Iran, two from Saudi Arabia, two from Qatar, one from Jordan, and one from Bahrain. The remaining study included 29 countries from Africa, Asia, Latin America, and the Middle East of which data from Jordan, Lebanon, the Occupied Palestinian Territory, and Qatar were included. There were four retrospective, two cross-sectional, and two cohort studies, one prospective study, one meta-analysis, and one descriptive-analytical study. The prevalence of pre-eclampsia in the studies ranged from 0.17 to 5%. We did not find any study investigating the prevalence of pre-eclampsia in the United Arab Emirates. Based on our findings, we conclude that there is a significant scarcity of research in this area, especially within the Middle East, and notably an absence of studies specifically pertaining to the UAE. Consequently, we assert that there is a pressing requirement for additional research to evaluate the prevalence of pre-eclampsia in the region.
妊娠高血压疾病是全球孕产妇死亡的第二大常见原因。代谢综合征被认为是子痫前期的危险因素之一。最近的一项研究显示,阿拉伯联合酋长国(阿联酋)的代谢综合征患病率很高,尤其是与全球估计相比,阿联酋女性的患病率更高。这一发现表明,该地区子痫前期的患病率也可能更高,因为越来越多的研究表明子痫前期与代谢综合征之间存在关联。因此,我们进行了这项文献范围综述,以调查评估中东地区子痫前期患病率的研究的性质和范围,以便随后将这些发现与子痫前期的全球负担进行比较,客观地确定文献中的空白,并为解决这些空白提供未来研究的设计。我们使用 PubMed 和 Scopus 提取了过去 20 年(2003-2023 年)发表的研究。使用的搜索词包括("子痫前期"和"患病率")或("妊娠高血压"和"患病率")或("妊娠"和"子痫前期")或("子痫前期"和"流行病学")。我们将研究仅限于中东(ME)。经过筛选,共有 556 篇相关文章,其中 11 篇被选入综述。有 4 项来自伊朗,2 项来自沙特阿拉伯,2 项来自卡塔尔,1 项来自约旦,1 项来自巴林。其余的研究包括来自非洲、亚洲、拉丁美洲和中东的 29 个国家,其中包括来自约旦、黎巴嫩、被占领巴勒斯坦领土和卡塔尔的数据。有 4 项回顾性研究、2 项横断面研究、2 项队列研究、1 项前瞻性研究、1 项荟萃分析和 1 项描述性分析研究。研究中子痫前期的患病率从 0.17%到 5%不等。我们没有发现任何研究调查阿联酋子痫前期的患病率。根据我们的发现,我们得出结论,该领域的研究非常匮乏,特别是在中东,特别是缺乏专门针对阿联酋的研究。因此,我们断言,有必要进行更多的研究来评估该地区子痫前期的患病率。